Immutopics specializes in innovative assays for assessing bone health. Since 1989, it has been a leading source of diagnostic kits for pre-clinical studies in bone and mineral metabolism for human, rat, mouse and other mammalian models. ELISA and IRMA test kits are available for the quantitative determination of FGF-23, several forms of PTH, Osteocalcin, Calcitonin and related peptides.

Immutopics products have been used in numerous published studies, including articles in the Journal of Bone and Mineral Research, Calcified Tissue International, Endocrine, and Bone and Mineral.

The company’s customers include: drug research organizations, pharmaceutical companies, contract research organizations, universities, and centers for clinical studies.